We read with interest the recent article by Butenas et al,[1][1] who conclude that the prohemostatic effect of high-dose factor VIIa in hemophilic blood or a synthetic plasma system is strictly dependent on tissue factor (TF). The authors note that their proposed mechanism differs from our
No takes yet. Share an insight, caveat, or question.
Hoffman et al. (2002) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: